Molecular epidemiology of respiratory syncytial virus

Reviews in Medical Virology

Volumn 11, Issue 2, 2001, Pages 103-116

  Cane, Patricia A ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; RESPIRATORY SYNCYTIAL VIRUS VACCINE;

GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; LOWER RESPIRATORY TRACT INFECTION; MOLECULAR DYNAMICS; MOLECULAR EVOLUTION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVIEW; VACCINATION;

ADULT; AGED; CHILD, PRESCHOOL; DISEASE OUTBREAKS; EPIDEMIOLOGY, MOLECULAR; HUMANS; INFANT; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN;

EID: 0035057112     PISSN: 10529276     EISSN: None     Source Type: Journal    
DOI: 10.1002/rmv.305     Document Type: Review

References (102)

1. Respiratory syncytial virus infection: Admissions to hospital in industrial, urban, and rural areas
2. Respiratory syncytial viral infection in infants with congenital heart disease
3. Nosocomial transmission of respiratory syncytial virus in immunocompromised adults
4. Respiratory syncytial virus infection in adults
5. RSV pneumonia, a community-acquired infection in adults
6. Respiratory syncytial virus pneumonia among the elderly: An assessment of disease burden
7. Impact of influenza and respiratory syncytial virus on mortality in England and Wales from January 1975 to December 1990
8. Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children
9. Risk of primary infection and reinfection with respiratory syncytial virus
10. Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level
11. Respiratory syncytial virus infections within families
12. Seroepidemiological study of respiratory syncytial virus in Sao Paulo state, Brazil
13. Pulmonary function changes in children after respiratory syncytial virus infection in infancy
14. Prevention and treatment of respiratory syncytial virus and parainfluenza viruses in immunocompromised patients
15. Active and passive immunisation against respiratory syncytial virus
16. The order Mononegavirales - Current status
17. The molecular biology of human respiratory syncytial virus (RSV) of the genus Pneumovirus
18. Role of the M2-1 transcription antitermination protein of respiratory syncytial virus in sequential transcription
19. Bovine respiratory syncytial virus nonstructural proteins NS1 and NS2 cooperatively antagonise alpha/beta interferon-induced antiviral response
20. Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5′ proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development
21. Paramyxovirus replication and pathogenesis. Reverse genetics transforms understanding
22. Detection of respiratory syncytial virus, parainfluenzavirus 3, adenovirus and rhinovirus sequences in respiratory tract of infants by polymerase chain reaction and hybridisation
23. Respiratory viruses in adult liver transplant recipients
24. Serologic evidence of respiratory syncytial virus infection in nursing home patients
25. Evaluation of four methods for the diagnosis of respiratory syncytial virus infection in older adults
26. Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalised adults
27. Estimation of incidence of respiratory syncytial virus infection in schoolchildren using salivary antibodies
28. Effect of age and preexisting antibody on serum antibody response of infants and children to the F and G glycoproteins during respiratory syncytial virus infection
29. Viral etiology and epidemiology of acute respiratory infections in children in Nairobi, Kenya
30. Seasonal variation in respiratory syncytial virus infections in children in Benin-City, Nigeria
31. Bronchiolitis in tropical south India
32. Epidemiology and aetiology of acute bronchiolitis in Hong Kong infants
33. The clinical spectrum of respiratory syncytial virus disease in the Gambia
34. An antigenic analysis of respiratory syncytial virus isolates by a plaque reduction neutralisation test
35. Antigenic characterisation of respiratory syncytial virus strains with monoclonal antibodies
36. Two distinct subtypes of human respiratory syncytial virus
37. Antigenic variation between human respiratory syncytial virus isolates
38. The fusion glycoproteins of human respiratory syncytial virus of subgroups A and B: Sequence conservation provides a structural basis for antigenic relatedness
39. The 1B (NS2), 1C (NS1) and N proteins of human respiratory syncytial virus (RSV) of antigenic subgroups A and B: Sequence conservation and divergence within RSV genomic RNA
40. The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: Extensive sequence divergence between antigenically related proteins
41. Multicentre study of strains of respiratory syncytial virus
42. Respiratory syncytial virus: Heterogeneity of subgroup B strains
43. Three antigenic variant groups in human respiratory syncytial virus subgroup B isolated in Japan
44. Preparation and characterisation of monoclonal antibodies directed against five structural components of human respiratory syncytial virus subgroup B
45. Monoclonal antibodies demonstrate heterogeneity in the G glycoprotein of prototype strains and clinical isolates of respiratory syncytial virus
46. RNA fingerprinting of respiratory syncytial virus using ribonuclease protection. Application to molecular epidemiology
47. Antigenic and genomic diversity within group A respiratory syncytial virus
48. Evolution of the G and P genes of human respiratory syncytial virus (subgroup A) studied by the RNase A mismatch cleavage method
49. Identification of variable domains of the attachment (G) protein of subgroup A respiratory syncytial viruses
50. Genetic diversity of the attachment protein of subgroup B respiratory syncytial viruses
51. Molecular epidemiology of respiratory syncytial virus: Rapid identification of subgroup A lineages
52. Analysis of respiratory syncytial virus genetic variability with amplified cDNAs
53. Concurrent circulation of antigenically distinct strains of respiratory syncytial virus during community outbreaks
54. Respiratory syncytial virus: Heterogeneity of subgroup B strains
55. Prevalence of respiratory syncytial virus subgroups over six consecutive outbreaks: 1981-1987
56. Prevalence of respiratory syncytial virus subgroups A and B in France from 1982 to 1990
57. Clinical and epidemiological aspects of respiratory syncytial virus antigenic variants in Argentinian children
58. Comparative virulence of respiratory syncytial virus subgroups A and B
59. Occurrence of respiratory syncytial virus subgroup A and B strains in Japan, 1980 to 1987
60. Antigenic diversity of respiratory syncytial virus subgroup B strains circulating during a community outbreak of infection
61. Respiratory syncytial virus: Changes in prevalence of subgroups A and B among Argentinian children, 1990-1996
62. Pattern of respiratory syncytial virus epidemics in Finland: Two-year cycles with alternating prevalence of groups A and B
63. Occurrence of groups A and B of respiratory syncytial virus over 15 years: Associated epidemiologic and clinical characteristics in hospitalised and ambulatory children
64. Evolutionary pattern of human respiratory syncytial virus (subgroup A): Cocirculating lineages and correlation of genetic and antigenic changes in the G glycoprotein
65. Analysis of respiratory syncytial virus strain variation in successive epidemics in one city
66. Genetic diversity and molecular epidemiology of the G protein of subgroups A and B of respiratory syncytial virus isolated over 9 consecutive epidemics in Korea
67. Circulation patterns of genetically distinct group A and B strains of human respiratory syncytial virus in a community
68. Genetic variability among group A and B respiratory syncytial viruses in a children's hospital
69. Molecular epidemiology of respiratory syncytial virus in the Gambia
70. Circulation patterns of group A and B human respiratory syncytial virus genotypes in 5 communities in North America
71. Epidemic infections caused by respiratory syncytial virus in institutionalised young adults
72. An outbreak of respiratory syncytial virus in a bone marrow transplant centre
73. The outcome of 26 patients with respiratory syncytial virus infection following allogeneic stem cell transplantation
74. Analysis of relatedness of subgroup A respiratory syncytial viruses isolated worldwide
75. Respiratory syncytial virus genetic and antigenic diversity
76. Nucleotide sequence of the G protein gene of human respiratory syncytial virus reveals an unusual type of viral membrane protein
77. Further characterisation of the soluble form of the G glycoprotein of respiratory syncytial virus
78. The membrane-associated and secreted forms of the respiratory syncytial virus attachment glycoprotein G are synthesised from alternative initiation codons
79. Human cytotoxic T cells stimulated by antigen on dendritic cells recognise the N, SH, F, M 22K, and 1b proteins of respiratory syncytial virus
80. Frame shift mutations as a novel mechanism for the generation of neutralisation resistant mutants of human respiratory syncytial virus
81. The three C-terminal residues of human respiratory syncytial virus G glycoprotein (Long strain) are essential for integrity of multiple epitopes distinguishable by antiidiotypic antibodies
82. Antigenic structure, evolution and immunobiology of human respiratory syncytial virus attachment (G) protein
83. Host cell effect upon glycosylation and antigenicity of human respiratory syncytial virus G glycoprotein
84. The C-terminal third of human respiratory syncytial virus attachment (G) protein is partially resistant to protease digestion and is glycosylated in a cell-type-specific manner
85. Site-directed serology with synthetic peptides representing the large glycoprotein G of respiratory syncytial virus
86. Analysis of the human serological immune response to a variable region of the attachment (G) protein of respiratory syncytial virus during primary infection
87. Analysis of linear epitopes recognised by the primary human antibody response to a variable region of the attachment (G) protein of respiratory syncytial virus
88. Evaluation of the antibody specificities of human convalescent-phase sera against the attachment (G) protein of human respiratory syncytial virus: Influence of strain variation and carbohydrate side chains
89. Immunity to and frequency of reinfection with respiratory syncytial virus
90. Determinants of susceptibility to challenge and the antibody response of adult volunteers given experimental respiratory syncytial virus vaccines
91. Subgroup characteristics of respiratory syncytial virus strains recovered from children with two consecutive infections
92. Immune and histopathological responses in animals vaccinated with recombinant vaccinia viruses that express individual genes of human respiratory syncytial virus
93. The respiratory syncytial virus subgroup B attachment glycoprotein: Analysis of sequence, expression from a recombinant vector, and evaluation as an immunogen against homologous and heterologous subgroup virus challenge
94. Antigenic and genetic diversity among the attachment proteins of group A respiratory syncytial viruses that have caused repeat infections in children
95. Evolution of subgroup A respiratory syncytial virus: Evidence for progressive accumulation of amino acid changes in the attachment protein
96. Evolutionary pattern of the G glycoprotein of human respiratory syncytial viruses from antigenic group B: The use of alternative termination codons and lineage diversification
97. Unusual antigenic and genetic characteristics of human respiratory syncytial viruses isolated in Cuba
98. Restriction pattern variability of respiratory syncytial virus during three consecutive epidemics in Denmark
99. Genetic variability in envelope-associated protein genes of closely related group A strains of respiratory syncytial virus
100. Evolution of bovine respiratory syncytial virus
101. Mutations of respiratory syncytial virus attachment glycoprotein G associated with resistance to neutralisation by primate polyclonal antibodies
102. Severity of respiratory syncytial virus infection is related to virus strain